Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McShane

Showing results (181-190 of 265) with videos related to

Pageof 27
Sort By:
Plos One|September 29, 2025
Impact of COVID-19 on breast cancer patients and services in a UK region: Protocol for a mixed methods studyHelen Julia Mitchell, Charlene M McShane, Sinéad Teresa Hawkins, et al.
Radiology|August 13, 2015
Metrology Standards for Quantitative Imaging BiomarkersDaniel C Sullivan, Nancy A Obuchowski, Larry G Kessler, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 15, 2005
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRIKa-Loh Li, Lisa J Wilmes, Roland G Henry, et al.
British Journal of Cancer|November 25, 2010
Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survivalM Rotunno, Y Zhao, A W Bergen, et al.
JNCI Cancer Spectrum|December 18, 2020
A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its PrecursorJonathan N Hofmann, Ola Landgren, Rebecca Landy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 1998
An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?L M McShane, M Kulldorff, M J Wargovich, et al.
JCO Precision Oncology|December 5, 2024
Discovery of Gene Fusions in Driver-Negative Cancer Samples From the National Cancer Institute-Molecular Analysis for Therapy Choice Screening CohortStefan T Kaluziak, Elizabeth M Codd, Rashi Purohit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline UpdateN Lynn Henry, Mark R Somerfield, Zoneddy Dayao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
MicroRNA expression differentiates histology and predicts survival of lung cancerMaria Teresa Landi, Yingdong Zhao, Melissa Rotunno, et al.
Pageof 27

Showing results (181-190 of 265) with videos related to

Sort By:
Pageof 27
Plos One|September 29, 2025
Impact of COVID-19 on breast cancer patients and services in a UK region: Protocol for a mixed methods studyHelen Julia Mitchell, Charlene M McShane, Sinéad Teresa Hawkins, et al.
Radiology|August 13, 2015
Metrology Standards for Quantitative Imaging BiomarkersDaniel C Sullivan, Nancy A Obuchowski, Larry G Kessler, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 15, 2005
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRIKa-Loh Li, Lisa J Wilmes, Roland G Henry, et al.
British Journal of Cancer|November 25, 2010
Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survivalM Rotunno, Y Zhao, A W Bergen, et al.
JNCI Cancer Spectrum|December 18, 2020
A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its PrecursorJonathan N Hofmann, Ola Landgren, Rebecca Landy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 1998
An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?L M McShane, M Kulldorff, M J Wargovich, et al.
JCO Precision Oncology|December 5, 2024
Discovery of Gene Fusions in Driver-Negative Cancer Samples From the National Cancer Institute-Molecular Analysis for Therapy Choice Screening CohortStefan T Kaluziak, Elizabeth M Codd, Rashi Purohit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline UpdateN Lynn Henry, Mark R Somerfield, Zoneddy Dayao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
MicroRNA expression differentiates histology and predicts survival of lung cancerMaria Teresa Landi, Yingdong Zhao, Melissa Rotunno, et al.
Pageof 27